Cellular receptor for the human polyomavirus, JCV

人多瘤病毒 (JCV) 的细胞受体

基本信息

  • 批准号:
    6874337
  • 负责人:
  • 金额:
    $ 25.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-09-01 至 2007-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The initial event in the life cycle of a virus is its interaction with receptors present on the surface of a cell. Understanding these interactions is important to our understanding of viral tropism, spread, and pathogenesis. The human polyomavirus, JCV, is the etiological agent of the fatal central nervous system (CNS) demyelinating disease, progressive multifocal leukoencephalopathy (PML). JCV has also been associated with several human tumors, including oligoastrocytoma and medulloblastoma. Following primary infection, JCV establishes a lifelong persistent infection in kidney and lymphoid tissues. In a minority of individuals, the virus spreads to the CNS, infecting both oligodendrocytes and astrocytes. The mechanisms that restrict JCV tropism for these cells and tissues and the mechanisms that allow for the spread of JCV from the periphery to the CNS are not understood. Our laboratory has been studying early events in the life cycle of JCV. We have determined that: 1. an N-linked glycoprotein containing terminal alpha (2-6) linked sialic acid is a critical component of the JCV receptor; 2. JCV and the related polyomavirus, SV40, do not share receptor specificity; and, 3. JCV, unlike SV40, enters cells by clathrin dependent receptor mediated endocytosis. The long term goals of our research are to define the role of virus receptors in mediating infection of cells and in determining viral tropism, spread, and pathogenesis in the infected host. Our working hypothesis, which is based on our previous work, is that JCV receptor interactions are critical determinants of viral entry, tropism, and spread within the host. We will address this hypothesis by asking the following questions: 1. What is the identity of the JCV receptor? 2. What are the cell and tissue distributions of JCV receptors? and 3. How does JCV penetrate the plasma membrane and target its genome to the nucleus? The data resulting from these studies will yield novel insights into the pathogenesis of JCV induced disease and may lead to novel therapies to prevent or treat these diseases.
描述(由申请人提供):a生命周期中的初始事件

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Walter J Atwood其他文献

Walter J Atwood的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Walter J Atwood', 18)}}的其他基金

Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
进行性多灶性白质脑病:地方性病毒和致命性脑病
  • 批准号:
    10393583
  • 财政年份:
    2020
  • 资助金额:
    $ 25.21万
  • 项目类别:
Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease
进行性多灶性白质脑病:地方性病毒和致命性脑病
  • 批准号:
    10604314
  • 财政年份:
    2020
  • 资助金额:
    $ 25.21万
  • 项目类别:
CENTER FOR CANCER SIGNALING NETWORKS
癌症信号网络中心
  • 批准号:
    8364911
  • 财政年份:
    2011
  • 资助金额:
    $ 25.21万
  • 项目类别:
Center for Cancer Signaling Networks
癌症信号网络中心
  • 批准号:
    8251146
  • 财政年份:
    2011
  • 资助金额:
    $ 25.21万
  • 项目类别:
Center for Cancer Signaling Networks
癌症信号网络中心
  • 批准号:
    8442850
  • 财政年份:
    2011
  • 资助金额:
    $ 25.21万
  • 项目类别:
Center for Cancer Signaling Networks
癌症信号网络中心
  • 批准号:
    8115529
  • 财政年份:
    2011
  • 资助金额:
    $ 25.21万
  • 项目类别:
Center for Cancer Signaling Networks
癌症信号网络中心
  • 批准号:
    8649060
  • 财政年份:
    2011
  • 资助金额:
    $ 25.21万
  • 项目类别:
Center for Cancer Signaling Networks
癌症信号网络中心
  • 批准号:
    8829305
  • 财政年份:
    2011
  • 资助金额:
    $ 25.21万
  • 项目类别:
Structure-function based development of JC virion specific antagonists for PML
基于结构-功能的 JC 病毒颗粒特异性 PML 拮抗剂的开发
  • 批准号:
    8304292
  • 财政年份:
    2009
  • 资助金额:
    $ 25.21万
  • 项目类别:
Structure-function based development of JC virion specific antagonists for PML
基于结构-功能的 JC 病毒颗粒特异性 PML 拮抗剂的开发
  • 批准号:
    8789634
  • 财政年份:
    2009
  • 资助金额:
    $ 25.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了